Rationale and design of a global registry to evaluate real‐world clinical outcomes in patients with atrial fibrillation and high risk of stroke treated with left atrial appendage occlusion using the AMPLATZER amulet device—Perspective of available/ongoing registries of catheter‐based LAA occlusion

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 91, Iss. 3, 2018-02 ,pp. : 540-547

John Wiley & Sons Inc

Access to resources Recommend Favorite

Short‐term safety and efficacy of left atrial appendage closure with the WATCHMAN device in patients with small left atrial appendage ostia

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 29, Iss. 1, 2018-01 ,pp. : 17-21

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early results with the LARIAT device for left atrial appendage exclusion in patients with atrial fibrillation at high risk for stroke and anticoagulation

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 1, 2015-07 ,pp. : 121-127

John Wiley & Sons Inc

Access to resources Recommend Favorite

Embolization of left atrial appendage closure devices: A systematic review of cases reported with the watchman device and the amplatzer cardiac plug

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 1, 2015-07 ,pp. : 128-135

John Wiley & Sons Inc

Access to resources Recommend Favorite

Feasibility of percutaneous left atrial appendage closure using a novel LAmbre occluder in patients with atrial fibrillation: Initial results from a prospective cohort registry study

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 29, Iss. 2, 2018-02 ,pp. : 291-297

John Wiley & Sons Inc

Access to resources Recommend Favorite